VERV - Verve Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VERV is currently covered by 6 analysts with an average price target of $22.27. This is a potential upside of $11.14 (100.09%) from yesterday's end of day stock price of $11.13.

Verve Therapeutics's activity chart (see below) currently has 19 price targets and 38 ratings on display. The stock rating distribution of VERV is 13.64% HOLD and 86.36% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.04% with an average time for these price targets to be met of 15.22 days.

Highest price target for VERV is $15, Lowest price target is $13, average price target is $15.8.

Most recent stock forecast was given by KOSTAS BILIOURIS from BMO on 27-Jun-2025. First documented stock forecast 12-Jul-2021.

Currently out of the existing stock ratings of VERV, 3 are a HOLD (13.64%), 19 are a BUY (86.36%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$13.5

$2.37 (21.29%)

$30

2 months 16 days ago
(27-Jun-2025)

0/3 (0%)

$2.2 (19.47%)

Buy

$13.5

$2.37 (21.29%)

$25

2 months 25 days ago
(18-Jun-2025)

0/7 (0%)

$2.38 (21.40%)

Buy

$13

$1.87 (16.80%)

$39

2 months 26 days ago
(17-Jun-2025)

0/7 (0%)

$1.62 (14.24%)

Hold

$22

4 months 28 days ago
(15-Apr-2025)

1/3 (33.33%)

$9 (69.23%)

8

Buy

$15

$3.87 (34.77%)

$17

6 months 8 days ago
(04-Mar-2025)

0/7 (0%)

$8.83 (143.11%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VERV (Verve Therapeutics) average time for price targets to be met?

On average it took 15.22 days on average for the stock forecasts to be realized with a an average price target met ratio 12.04

Which analyst has the current highest performing score on VERV (Verve Therapeutics) with a proven track record?

ETZER DAROUT

Which analyst has the current lower performing score on VERV (Verve Therapeutics) with a proven track record?

ERIC JOSEPH

Which analyst has the most public recommendations on VERV (Verve Therapeutics)?

Etzer Darout works at BMO and has 12 price targets and 8 ratings on VERV

Which analyst is the currently most bullish on VERV (Verve Therapeutics)?

Dae Gon Ha with highest potential upside - $44.87

Which analyst is the currently most reserved on VERV (Verve Therapeutics)?

Etzer Darout with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?